
Solving the CGT Workforce Deficit & 50% CAR-T Attrition Gap | Dr. Shernan Holtan
Despite rapid innovation in cell and gene therapy, clinical operational bottlenecks from severe workforce deficits to high geographic attrition continue to limit patient access.
In this episode of Out of the Lab, host Nico Crudele sits down with Dr. Shernan Holtan, Chief of Blood and Marrow Transplantation and Professor of Medicine at Roswell Park Comprehensive Cancer Center. Dr. Holtan breaks down the workforce shortage facing cell therapy, the physiological reality of clinical decision fatigue, and why nearly 50% of referred CAR-T patients never receive treatment. She outlines practical operational solutions, including personalized clinical scheduling, predictive toxicity biomarkers (ferritin, CRP, physical mobility metrics), and Roswell Park's innovative Hub-and-Spoke shared care model designed to bring advanced therapies closer to community settings.
Timestamps & Key Topics:
00:00:00 – Introduction & The Clinical Workforce Shortfall 00:05:00 – Why Medical Trainees Bypass Cell Therapy & BMT
00:08:48 – The 1,300 Physician Deficit & Post-Pandemic Burnout
00:15:43 – 400 Decisions a Day: Addressing Clinical Decision Fatigue
00:20:00 – The 50% Attrition Rate: Travel and Logistical Barriers in Rural Access
00:23:05 – Decentralizing Delivery: The "Hub-and-Spoke" Shared Care Model
00:28:03 – Standardizing Contingency Planning & The Role of APPs
00:31:31 – Operationalizing Predictability: Ferritin, CRP, and Physical Mobility Scoring
More episodes from "Out of the Lab Podcast"



Don't miss an episode of “Out of the Lab Podcast” and subscribe to it in the GetPodcast app.








